"Standard of Care" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The minimum acceptable patient care, based on statutes, court decisions, policies, or professional guidelines.
| Descriptor ID |
D059039
|
| MeSH Number(s) |
N04.761.789.900 N05.715.840
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Standard of Care".
Below are MeSH descriptors whose meaning is more specific than "Standard of Care".
This graph shows the total number of publications written about "Standard of Care" by people in this website by year, and whether "Standard of Care" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 2 | 3 |
| 2011 | 0 | 3 | 3 |
| 2012 | 1 | 3 | 4 |
| 2013 | 4 | 1 | 5 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 4 | 5 |
| 2016 | 6 | 4 | 10 |
| 2017 | 4 | 4 | 8 |
| 2018 | 2 | 14 | 16 |
| 2019 | 4 | 13 | 17 |
| 2020 | 1 | 9 | 10 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 23 | 23 |
| 2023 | 2 | 26 | 28 |
| 2024 | 4 | 29 | 33 |
To return to the timeline,
click here.
Below are the most recent publications written about "Standard of Care" by people in Profiles.
-
Janus kinase inhibitor monotherapy and combination therapies for myelofibrosis: what's the current standard of care? Expert Rev Hematol. 2024 Nov; 17(11):769-780.
-
A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia. J Antimicrob Chemother. 2024 Oct 01; 79(10):2543-2553.
-
Is luspatercept the new standard of care in transfusion-dependent low-risk myelodysplastic syndromes? Clin Adv Hematol Oncol. 2024 Oct; 22(8):367-369.
-
Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial. Pract Radiat Oncol. 2024 Nov-Dec; 14(6):e500-e506.
-
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium. J Clin Oncol. 2024 Oct 20; 42(30):3581-3592.
-
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer. Mol Cancer. 2024 Aug 02; 23(1):156.
-
Should enhanced monofocal intraocular lenses be the standard of care? An evidence-based appraisal by the ESCRS Functional Vision Working Group. J Cataract Refract Surg. 2024 Aug 01; 50(8):789-793.
-
ASO Author Reflections: The Path to Standardizing Surgical Cancer Care in the USA. Ann Surg Oncol. 2024 Oct; 31(10):6406-6407.
-
Curbing the Obesity Epidemic: Should GLP-1 Receptor Agonists Be the Standard of Care for Obesity? Curr Cardiol Rep. 2024 Sep; 26(9):1011-1019.
-
Malignant Peripheral Nerve Sheath Tumor, a Heterogeneous, Aggressive Cancer with Diverse Biomarkers and No Targeted Standard of Care: Review of the Literature and Ongoing Investigational Agents. Target Oncol. 2024 Sep; 19(5):665-678.